Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
针对 IV 期非小细胞肺癌患者，对自佐剂鱼精蛋白配制的基于 mRNA 的主动癌症免疫疗法 BI1361849 (CV9202) 进行 Ib 期评估，并联合局部放射治疗
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1186/s40425-019-0520-5
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas S
